Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

Creative Commons License

Gutierrez-Gutierrez B., Salamanca E., de Cueto M., Hsueh P., Viale P., Ramon Pano-Pardo J., ...Daha Fazla

LANCET INFECTIOUS DISEASES, cilt.17, sa.7, ss.726-734, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 17 Sayı: 7
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1016/s1473-3099(17)30228-1
  • Dergi Adı: LANCET INFECTIOUS DISEASES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.726-734
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Background The best available treatment against carbapenemase-producing Enterobacteriaceae (CPE) is unknown. The objective of this study was to investigate the effect of appropriate therapy and of appropriate combination therapy on mortality of patients with bloodstream infections (BSIs) due to CPE.